Literature DB >> 24292267

SPOCK3, a risk gene for adult ADHD and personality disorders.

Heike Weber1, Claus-Jürgen Scholz, Christian P Jacob, Julia Heupel, Sarah Kittel-Schneider, Angelika Erhardt, Susanne Hempel, Brigitte Schmidt, Tilman Kiel, Alexandra Gessner, Klaus-Peter Lesch, Andreas Reif.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is the most frequent psychiatric disorder in children, where it displays a global prevalence of 5 %. In up to 50 % of the cases, ADHD may persist into adulthood (aADHD), where it is often comorbid with personality disorders. Due to a potentially heritable nature of this comorbidity, we hypothesized that their genetic framework may contain common risk-modifying genes. SPOCK3, a poorly characterized, putatively Ca(2+)-binding extracellular heparan/chondroitin sulfate proteoglycan gene encoded by the human chromosomal region 4q32.3, was found to be associated with polymorphisms among the top ranks in a genome-wide association study (GWAS) on ADHD and a pooled GWAS on personality disorder (PD). We therefore genotyped 48 single nucleotide polymorphisms (SNPs) representative of the SPOCK3 gene region in 1,790 individuals (n aADHD = 624, n PD = 630, n controls = 536). In this analysis, we found two SNPs to be nominally associated with aADHD (rs7689440, rs897511) and four PD-associated SNPs (rs7689440, rs897511, rs17052671 and rs1485318); the latter even reached marginal significance after rigorous Bonferroni correction. Bioinformatics tools predicted a possible influence of rs1485318 on transcription factor binding, whereas the other candidate SNPs may have effects on alternative splicing. Our results suggest that SPOCK3 may modify the genetic risk for ADHD and PD; further studies are, however, needed to identify the underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292267     DOI: 10.1007/s00406-013-0476-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  58 in total

Review 1.  Extracellular matrix and the brain: components and function.

Authors:  U Novak; A H Kaye
Journal:  J Clin Neurosci       Date:  2000-07       Impact factor: 1.961

2.  The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function.

Authors:  Chozhavendan Rathinam; Robert Geffers; Raif Yücel; Jan Buer; Karl Welte; Tarik Möröy; Christoph Klein
Journal:  Immunity       Date:  2005-06       Impact factor: 31.745

3.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap.

Authors:  Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

Review 4.  Lost in the space of bioinformatic tools: a constantly updated survival guide for genetic epidemiology. The GenEpi Toolbox.

Authors:  Stefan Coassin; Anita Brandstätter; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2009-10-29       Impact factor: 5.162

5.  A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication.

Authors:  M Arcos-Burgos; M Jain; M T Acosta; S Shively; H Stanescu; D Wallis; S Domené; J I Vélez; J D Karkera; J Balog; K Berg; R Kleta; W A Gahl; E Roessler; R Long; J Lie; D Pineda; A C Londoño; J D Palacio; A Arbelaez; F Lopera; J Elia; H Hakonarson; S Johansson; P M Knappskog; J Haavik; M Ribases; B Cormand; M Bayes; M Casas; J A Ramos-Quiroga; A Hervas; B S Maher; S V Faraone; C Seitz; C M Freitag; H Palmason; J Meyer; M Romanos; S Walitza; U Hemminger; A Warnke; J Romanos; T Renner; C Jacob; K-P Lesch; J Swanson; A Vortmeyer; J E Bailey-Wilson; F X Castellanos; M Muenke
Journal:  Mol Psychiatry       Date:  2010-02-16       Impact factor: 15.992

6.  Expression profile of differentiating serotonin neurons derived from rhesus embryonic stem cells and comparison to adult serotonin neurons.

Authors:  Cynthia L Bethea; Arubala P Reddy; Darlene Pedersen; Yukari Tokuyama
Journal:  Gene Expr Patterns       Date:  2008-11-01       Impact factor: 1.224

7.  Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis.

Authors:  Antonio Alcina; Oscar Fernández; Juan Ramón Gonzalez; Antonio Catalá-Rabasa; María Fedetz; Dorothy Ndagire; Laura Leyva; Miguel Guerrero; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; Fuencisla Matesanz
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

8.  Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation.

Authors:  Sarah Durston; John A Fossella; Martijn J Mulder; B J Casey; Tim B Ziermans; M Nathalie Vessaz; Herman VAN Engeland
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-01       Impact factor: 8.829

9.  Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter.

Authors:  Jennifer J Westendorf; S Kaleem Zaidi; Jonathan E Cascino; Rachel Kahler; André J van Wijnen; Jane B Lian; Minoru Yoshida; Gary S Stein; Xiaodong Li
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

10.  Otx2 controls identity and fate of glutamatergic progenitors of the thalamus by repressing GABAergic differentiation.

Authors:  Eduardo Puelles; Dario Acampora; Robindra Gogoi; Francesca Tuorto; Alessandro Papalia; Francois Guillemot; Siew-Lan Ang; Antonio Simeone
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

View more
  7 in total

1.  Historical aspects of Mozart's mental health and diagnostic insights of ADHD and personality disorders.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08       Impact factor: 5.270

Review 2.  Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder.

Authors:  Cristian Bonvicini; Stephen V Faraone; Catia Scassellati
Journal:  World J Biol Psychiatry       Date:  2017-02-24       Impact factor: 4.132

Review 3.  Comorbidity of Personality Disorders and Adult Attention Deficit Hyperactivity Disorder (ADHD)--Review of Recent Findings.

Authors:  Swantje Matthies; Alexandra Philipsen
Journal:  Curr Psychiatry Rep       Date:  2016-04       Impact factor: 5.285

4.  The role of ASTN2 variants in childhood and adult ADHD, comorbid disorders and associated personality traits.

Authors:  Christine M Freitag; Thomas Lempp; T Trang Nguyen; Christian P Jacob; Lena Weissflog; Marcel Romanos; Tobias J Renner; Susanne Walitza; Andreas Warnke; Dan Rujescu; Klaus-Peter Lesch; Andreas Reif
Journal:  J Neural Transm (Vienna)       Date:  2016-04-30       Impact factor: 3.575

Review 5.  Nutrition, immunological mechanisms and dietary immunomodulation in ADHD.

Authors:  Annelies A J Verlaet; Daniela Briceno Noriega; Nina Hermans; Huub F J Savelkoul
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-02-04       Impact factor: 4.785

6.  Pathway analysis in attention deficit hyperactivity disorder: An ensemble approach.

Authors:  Michael A Mooney; Shannon K McWeeney; Stephen V Faraone; Anke Hinney; Johannes Hebebrand; Joel T Nigg; Beth Wilmot
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-03-22       Impact factor: 3.568

Review 7.  Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.

Authors:  C Bonvicini; S V Faraone; C Scassellati
Journal:  Mol Psychiatry       Date:  2016-05-24       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.